Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Heart Failure Risk with Onglyza, Similar Diabetes Drugs Lead to FDA Warnings April 6, 2016 Austin Kirk Add Your Comments In response to mounting concerns about the risk of heart failure with Onglyza and similar diabetes drugs, federal health regulators have announced that new safety warnings will be added to any medications containing saxagliptin and alogliptin. The FDA issued a drug safety communication on April 5, announcing the results of a review into the Onglyza heart failure risk that was launched in February 2014. New heart failure warnings will be required for the diabetes drugs Onglyza, Kombiglyze XR, Nesina, Kazano, and Oseni, which are part of a class of medications known as dipeptidyl peptidase-4 (DPP-4) inhibitors. Learn More About Onglyza Lawsuit Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Onglyza Lawsuit Learn More SEE IF YOU QUALIFY FOR COMPENSATION While the investigation has been ongoing, a growing number of Onglyza lawsuits have been filed in courts nationwide on behalf of individuals diagnosed with heart failure, alleging that the drug maker knew or should have known about the risk when the medication was first introduced, yet withheld adequate warnings from consumers and the medical community. Onglyza (saxagliptin) was developed jointly by AstraZeneca and Bristol-Myers Squibb, but is now owned wholly by AstraZeneca. It was approved by the FDA in July 2009, for treatment of type 2 diabetes and generated more than $700 million in sales in 2012. Concerns about the link between Onglyza and heart failure risks emerged following the publication of a study, known as “SAVOR”, by the New England Journal of Medicine in 2013. In April 2015, the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee voted 14-1 to recommend stronger warnings about the potential Onglyza heart risks, after a review of data from clinical trials suggested that users may face a higher than expected risk of hospitalization for heart failure and all-cause mortality. The review looked at two large clinical trials involving patients with heart disease. In both trials, patients given drugs containing saxagliptin or alogliptin were at a higher risk of being hospitalized for heart failure than those given a placebo. In the drug safety communication issued this week, the FDA recommends patients taking diabetes drugs containing saxagliptin and alogliptin contact a health care professional immediately if they develop heart failure symptoms, which can include: Unusual shortness of breath Problems breathing when lying down Fatigue or weakness Weight gain involving swelling of the ankles, feet, legs, or stomach. The agency cautions that patients should not stop taking their medication before first consulting with their health care professional. The FDA also recommends that health care professionals should consider a different medication if an individual develops heart failure on Onglyza, Nessina or other similar diabetes drugs. In July 2015, Onglyza was one of several drugs that the pharmacy benefits manager Express Scripts decided not to cover in its National Preferred Formulary, the most widely used formulary in the U.S. It’s prescription drug coverage guidelines affect which drugs are insured for about 25 million Americans. Reports and sources indicated that Express Scripts dropped Onglyza due to its health risks and because there were safer, comparably priced diabetes drugs on the market that did the same job. Tags: Diabetes, Diabetes Drugs, Heart Disease, Heart Failure, Kazano, Kidney Disease, Kombiglyze XR, Nesina, Onglyza, Oseni Image Credit: | More Onglyza Lawsuit Stories Heart Failure Lawsuit Filed Against Makers Of Onglyza November 19, 2018 Judge Splits Discovery in Onglyza Heart Failure Cases Into Two Phases November 1, 2018 Drug Makers Want Plaintiffs To Prove Link Between Onglyza and Heart Failure Before Claims Proceed October 19, 2018 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: today) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025) Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (Posted: yesterday) A California judge has ordered parties involved in a hair dye bladder cancer lawsuit filed against major cosmetic companies to meet for the first time this week to discuss the case. MORE ABOUT: HAIR DYE LAWSUITLawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025) Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (Posted: 4 days ago) A court status report indicates that Depo-Provera lawsuits are being filed at a rapid pace, and generic manufacturers are likely to be dismissed from the litigation. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)Lawsuit Indicates Depo-Provera Meningioma Growth Risks Created Constant Distress (06/06/2025)
Drug Makers Want Plaintiffs To Prove Link Between Onglyza and Heart Failure Before Claims Proceed October 19, 2018
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: today) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (Posted: yesterday) A California judge has ordered parties involved in a hair dye bladder cancer lawsuit filed against major cosmetic companies to meet for the first time this week to discuss the case. MORE ABOUT: HAIR DYE LAWSUITLawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)
Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (Posted: 4 days ago) A court status report indicates that Depo-Provera lawsuits are being filed at a rapid pace, and generic manufacturers are likely to be dismissed from the litigation. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)Lawsuit Indicates Depo-Provera Meningioma Growth Risks Created Constant Distress (06/06/2025)